Notably, overexpression of THBS2 in 5‐FU treatment‐enriched CD133+ HCC cells could sensitize the cells to chemotherapy (Figure S3, Supporting Information), further suggesting the significance of THBS2 in mediating this effect. Here, THBS2 is linked to hepatocellular carcinoma.